Clinical Research Center for Dementia of South Korea (CREDOS)

Samsung Medical Center1 site in 1 country800 target enrollmentNovember 2005

ConditionsAlzheimer's Disease

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Alzheimer's Disease
Sponsor: Samsung Medical Center
Enrollment: 800
Locations: 1
Last Updated: 13 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The objective of this study is to present evidence-based medicine for development of clinical practice guideline through prospective study of Alzheimer's disease(AD) and mild cognitive impairment(MCI) in korea

Detailed Description

The specific aims of this study is (1) construction \& maintenance of cohort for Alzheimer's disease(AD) and mild cognitive impairment(MCI); (2) study of epidemiology, rate of progression, risk factor, prognostic factor; (3) study of biomarker such as neuropsychological assessment, peripheral \& CSF markers, neuroimaging(both structural \& functional)

Registry

clinicaltrials.gov

Start Date

November 2005

End Date

August 2015

Last Updated

13 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Samsung Medical Center

Responsible Party

Principal Investigator

Doh Kwan Kim

Professor

Samsung Medical Center

Eligibility Criteria

Inclusion Criteria

•Alzheimer's disease(AD) and mild cognitive impairment(MCI)will be enrolled in the study.
•the diagnostic criteria of Alzheimer's disease(AD) according to DSM IV or NINCDS -ADRDA
•the diagnostic criteria of mild cognitive impairment(MCI) A. Memory or other cognitive complaint preferably corroborated by an informant B. Objective memory impairment or other cognitive for age and education C. Largely intact general cognitive function D. Essentially preserved ADL E. Not demented

Exclusion Criteria

•Exclusion criteria are current neurological or other psychiatric disorders, as well as a history of epileptic seizures, substantial brain damage or neurosurgical operation, according to established safety criteria.